[HTML][HTML] A novel risk score system of immune genes associated with prognosis in endometrial cancer
H Zhou, C Zhang, H Li, L Chen, X Cheng - Cancer cell international, 2020 - Springer
Background Endometrial cancer was the commonest gynecological malignancy in
developed countries. Despite striking advances in multimodality management, however, for …
developed countries. Despite striking advances in multimodality management, however, for …
A novel risk score system of immune genes associated with prognosis in endometrial cancer.
H Zhou, C Zhang, H Li, L Chen, X Cheng - Cancer Cell International, 2020 - go.gale.com
Background Endometrial cancer was the commonest gynecological malignancy in
developed countries. Despite striking advances in multimodality management, however, for …
developed countries. Despite striking advances in multimodality management, however, for …
[引用][C] A novel risk score system of immune genes associated with prognosis in endometrial cancer
H Zhou, C Zhang, H Li, L Chen… - Cancer Cell International …, 2020 - jglobal.jst.go.jp
A novel risk score system of immune genes associated with prognosis in endometrial
cancer | Article Information | J-GLOBAL Art J-GLOBAL ID:202102217761014976 Reference …
cancer | Article Information | J-GLOBAL Art J-GLOBAL ID:202102217761014976 Reference …
A novel risk score system of immune genes associated with prognosis in endometrial cancer.
H Zhou, C Zhang, H Li, L Chen… - Cancer Cell …, 2020 - search.ebscohost.com
Background: Endometrial cancer was the commonest gynecological malignancy in
developed countries. Despite striking advances in multimodality management, however, for …
developed countries. Despite striking advances in multimodality management, however, for …
A novel risk score system of immune genes associated with prognosis in endometrial cancer.
H Zhou, C Zhang, H Li, L Chen, X Cheng - Cancer Cell International, 2020 - europepmc.org
Background Endometrial cancer was the commonest gynecological malignancy in
developed countries. Despite striking advances in multimodality management, however, for …
developed countries. Despite striking advances in multimodality management, however, for …
A novel risk score system of immune genes associated with prognosis in endometrial cancer
H Zhou, C Zhang, H Li, L Chen… - Cancer Cell …, 2020 - search.proquest.com
Background Endometrial cancer was the commonest gynecological malignancy in
developed countries. Despite striking advances in multimodality management, however, for …
developed countries. Despite striking advances in multimodality management, however, for …
A novel risk score system of immune genes associated with prognosis in endometrial cancer
H Zhou, C Zhang, H Li, L Chen… - Cancer cell …, 2020 - pubmed.ncbi.nlm.nih.gov
Background Endometrial cancer was the commonest gynecological malignancy in
developed countries. Despite striking advances in multimodality management, however, for …
developed countries. Despite striking advances in multimodality management, however, for …
[HTML][HTML] A novel risk score system of immune genes associated with prognosis in endometrial cancer
H Zhou, C Zhang, H Li, L Chen… - Cancer Cell …, 2020 - cancerci.biomedcentral.com
Endometrial cancer was the commonest gynecological malignancy in developed countries.
Despite striking advances in multimodality management, however, for patients in advanced …
Despite striking advances in multimodality management, however, for patients in advanced …
[HTML][HTML] A novel risk score system of immune genes associated with prognosis in endometrial cancer
H Zhou, C Zhang, H Li, L Chen… - Cancer Cell …, 2020 - ncbi.nlm.nih.gov
Background Endometrial cancer was the commonest gynecological malignancy in
developed countries. Despite striking advances in multimodality management, however, for …
developed countries. Despite striking advances in multimodality management, however, for …
[PDF][PDF] A novel risk score system of immune genes associated with prognosis in endometrial cancer
H Zhou, C Zhang, H Li, L Chen, X Cheng - 2020 - cancerci.biomedcentral.com
Background: Endometrial cancer was the commonest gynecological malignancy in
developed countries. Despite striking advances in multimodality management, however, for …
developed countries. Despite striking advances in multimodality management, however, for …